- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Potential of antibody–drug conjugates (ADCs) for cancer therapy ; volume:22 ; number:1 ; day:13 ; month:8 ; year:2022 ; pages:1-12 ; date:12.2022
Cancer cell international ; 22, Heft 1 (13.8.2022), 1-12, 12.2022
- Creator
-
Marei, Hany E.
Cenciarelli, Carlo
Hasan, Anwarul
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-022-02679-8
- URN
-
urn:nbn:de:101:1-2022103119403341378093
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Marei, Hany E.
- Cenciarelli, Carlo
- Hasan, Anwarul
- SpringerLink (Online service)
Other Objects (12)
Antibody–drug conjugates in ovarian cancer
Antibody–drug conjugates—the magic bullet?
Antibody–drug conjugates as an emerging therapy in oncodermatology
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody–drug conjugates (ADCs) in lung cancer treatment
Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates
Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates
Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Antibody–drug conjugates in the treatment of lymphoid neoplasms
Research progress of antibody–drug conjugates in gynecologic cancer
Antibody–drug conjugates in ovarian cancer
Antibody–drug conjugates—the magic bullet?
Antibody–drug conjugates as an emerging therapy in oncodermatology
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody–drug conjugates (ADCs) in lung cancer treatment
Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates
Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates
Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Antibody–drug conjugates in the treatment of lymphoid neoplasms
Research progress of antibody–drug conjugates in gynecologic cancer
Antibody–drug conjugates in ovarian cancer
Antibody–drug conjugates—the magic bullet?
Antibody–drug conjugates as an emerging therapy in oncodermatology
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody–drug conjugates (ADCs) in lung cancer treatment
Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates
Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates
Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Antibody–drug conjugates in the treatment of lymphoid neoplasms